
Select Page
Beaver Creek, Colorado
January, 2020
The International Prostate Cancer Update (IPCU), founded in 1991, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. IPCU 30 will encompass expert lectures, interactive discussions, a panel roundtable, debates, and case reports. This conference is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer.
The goal of this educational program is to equip healthcare professionals involved in the diagnosis and treatment of prostate cancer with the up-to-date clinical knowledge and tools they need to best treat their patients. The program will discuss the treatment of prostate cancer from diagnosis to treating advanced and metastatic disease. The conference aims to give physicians exposure to a comprehensive review of treating prostate cancer patients, and to give them a chance to discuss the issues with peers and experts.
E. DAVID CRAWFORD, MD
Professor of Surgery, Urology and Radiation Oncology
E. David Crawford Endowed Chair in Urologic Oncology
University of Colorado, Denver
Aurora, CO
LUGPA is pleased to co-sponsor the 29th annual International Prostate Cancer Update (IPCU) with Grand Rounds in Urology™ in 2019. LUGPA members receive a discount on regular or onsite registration.
Educational Needs
The goal of this educational program is to equip healthcare professionals involved in the diagnosis and treatment of prostate cancer with the up-to-date clinical knowledge and tools they need to best treat their patients. The program will discuss the treatment of prostate cancer from diagnosis to treating advanced and metastatic disease. The conference aims to give physicians exposure to a comprehensive review of treating prostate cancer patients, and to give them a chance to discuss the issues with peers and experts.
CME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Carden Jennings Publishing. The Medical College of Wisconsin is accredited with commendation by the ACCME to provide continuing medical education for physicians.
We invite the submission of abstracts reflecting your latest findings in the fields of prostate cancer prevention, diagnosis, and management to be presented at the 30th International Prostate Cancer Update (IPCU 30), taking place from January, 2020 at the Westin Riverfront in Beaver Creek, Colorado, USA. Authors of accepted submissions will be invited to display a poster at the meeting, and selected poster authors will be asked to give a brief oral presentation during the poster session and reception.
Please submit an abstract of 500 words or less (single-spaced, 10-point size): include a title for the abstract. Spell out complete names of all authors. List the institution, city, state, country, and e-mail address of the presenting author. E-mail the document to David Utz at dutz@cjp.com.
PLATINUM SPONSOR
Astellas US Pharma/Pfizer Oncology
SILVER SPONSORS
Clovis Oncology
Tolmar Pharmaceuticals
AbbVie • Astellas US Pharma/Pfizer Oncology • AstraZeneca
Bayer HealthCare • BK Medical • Blue Earth Diagnostics
BTG • Clovis Oncology • Ferring Pharmaceuticals • ForTec Medical
Genomic Health • Grand Rounds in Urology • HealthTronics
IsoRay Medical • Janssen Biotech • LUGPA • Merck • MicroGen Dx
Prostate Conditions Education Council • Strand Diagnostics • Tolmar Pharmaceuticals